Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × Irinotecan × Clear all

NCT05427383 2023-12-19

KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

Phase 2/3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT04393584 2021-04-13

RusGCG-01

Phase 2/3 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms

NCT00639327 2011-06-28

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms